These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 37820596)

  • 21. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Twenty-four-week interim analysis from a phase 3 open-label trial of adalimumab in Japanese patients with moderate to severe hidradenitis suppurativa.
    Morita A; Takahashi H; Ozawa K; Imafuku S; Nakama T; Takahashi K; Matsuyama T; Okubo Y; Kitamura S; Matsuda N; Zhao Y; Yokoyama M; Hayashi N; Terui T
    J Dermatol; 2019 Sep; 46(9):745-751. PubMed ID: 31282051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
    Cuenca-Barrales C; Molina-Leyva A
    Dermatology; 2020; 236(1):37-45. PubMed ID: 31434072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development and Preliminary Validation of the HSQoL-24 Tool to Assess Quality of Life in Patients With Hidradenitis Suppurativa.
    Marrón SE; Gómez-Barrera M; Tomás-Aragonés L; Díaz Díaz RM; Vilarrasa Rull E; Madrid Álvarez MB; Puig L
    Actas Dermosifiliogr (Engl Ed); 2019 Sep; 110(7):554-560. PubMed ID: 31023484
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qualitative interviews to evaluate content validity of the ACTIV-2 COVID-19 Symptom Diary (ACSD).
    Matza LS; Stewart KD; Naegeli AN; Mills KM; Coyne KS; Chew KW; Hughes MD; Smith DM
    J Patient Rep Outcomes; 2023 Jan; 7(1):8. PubMed ID: 36719546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of Focal Segmental Glomerulosclerosis Patient-Reported Outcome Measures: Symptom Diary and Symptom Impact Questionnaire.
    Mathias SD; Vallow S; Gipson DS; Thorneloe KS; Sprecher D
    Am J Kidney Dis; 2017 Oct; 70(4):532-540. PubMed ID: 28663063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A qualitative analysis of psychological distress in hidradenitis suppurativa.
    Keary E; Hevey D; Tobin AM
    Br J Dermatol; 2020 Feb; 182(2):342-347. PubMed ID: 31099891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Severity of Chronic Cough Diary (SCCD): development and content validation of a novel patient-reported outcome instrument for evaluating the symptom experience of chronic cough.
    de la Orden Abad M; Haberland C; Karn H; Skalicky A; Hareendran A
    J Patient Rep Outcomes; 2023 Jul; 7(1):65. PubMed ID: 37428359
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Characteristics of Hidradenitis Suppurativa Patients from a Reference Centre in Kaunas, Lithuania.
    Kucinskiene V; Jariene V; Valiukeviciene S
    Dermatology; 2020; 236(1):66-70. PubMed ID: 31940646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Body Image Quality of Life in Patients with Hidradenitis Suppurativa Compared with Other Dermatological Disorders.
    Andersen PL; Nielsen RM; Sigsgaard V; Jemec GBE; Riis PT
    Acta Derm Venereol; 2020 Apr; 100(8):adv00107. PubMed ID: 32201901
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Content validity and electronic PRO (ePRO) usability of the Lung Cancer Symptom Scale-Mesothelioma (LCSS-Meso) in mesothelioma patients.
    Gelhorn HL; Skalicky AM; Balantac Z; Eremenco S; Cimms T; Halling K; Hollen PJ; Gralla RJ; Mahoney MC; Sexton C
    Support Care Cancer; 2018 Jul; 26(7):2229-2238. PubMed ID: 29392480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline Characteristics of a National French E-Cohort of Hidradenitis Suppurativa in ComPaRe and Comparison with Other Large Hidradenitis Suppurativa Cohorts.
    Condamina M; Penso L; Tran VT; Hotz C; Guillem P; Villani AP; Perrot P; Bru MF; Jacquet E; Nassif A; Bachelez H; Wolkenstein P; Beylot-Barry M; Richard MA; Ravaud P; Viguier M; Sbidian E
    Dermatology; 2021; 237(5):748-758. PubMed ID: 33503635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Reported Pain Alleviating Methods in Patients with Hidradenitis Suppurativa.
    Ravn Jørgensen AH; Yao Y; Thomsen SF; Christian Ring H
    Actas Dermosifiliogr (Engl Ed); 2021 Feb; 112(2):153-158. PubMed ID: 33232705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain experiences among those living with hidradenitis suppurativa: a qualitative study.
    Orenstein LAV; Salame N; Siira MR; Urbanski M; Flowers NI; Echuri H; Garg A; McKenzie-Brown AM; Curseen KA; Patzer RE; Kavalieratos D; Chen SC
    Br J Dermatol; 2023 Jan; 188(1):41-51. PubMed ID: 36689519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Qualitative Study to Assess the Content Validity of the 24-Hour Migraine Quality of Life Questionnaire in Patients with Migraine.
    Speck RM; Collins EM; Lombard L; Ayer DW
    Headache; 2020 Oct; 60(9):1982-1994. PubMed ID: 32748408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patient-reported outcomes in hidradenitis suppurativa.
    Vellaichamy G; Braunberger TL; Jones JL; Peacock A; Nahhas AF; Hamzavi IH
    G Ital Dermatol Venereol; 2019 Apr; 154(2):137-147. PubMed ID: 30375207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients.
    Macklis PC; Tyler K; Kaffenberger J; Kwatra S; Kaffenberger BH
    Arch Dermatol Res; 2022 Apr; 314(3):293-300. PubMed ID: 33893517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient experiences with hidradenitis suppurativa: the Hidradenitis Patient Experience survey.
    Kashetsky N; Mukovozov IM; Pereira J; Manion R; Carter S; Alhusayen R
    Clin Exp Dermatol; 2022 Jan; 47(1):72-79. PubMed ID: 34235774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-specific physical and mental health status in Italian patients with hidradenitis suppurativa: a comparison with the general population.
    Sampogna F; Fania L; Mastroeni S; Ciccone D; Panebianco A; Abeni D
    Arch Dermatol Res; 2021 Jan; 313(1):41-47. PubMed ID: 32270321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of Internalized Skin Bias With Age, Adverse Psychopathology, and Health-Related Quality of Life Among Patients With Hidradenitis Suppurativa: A Cross-sectional Analysis.
    Butt M; Rigby A; Leslie DL; Foulke GT; Flamm A; Kirby JS; Chinchilli VM
    JAMA Dermatol; 2022 Apr; 158(4):432-438. PubMed ID: 35293961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.